Target intelligence / Profile preview

Brain activity

Molecular classification
Other
01

Overview

Brain activity refers to the collective electrochemical processes within the central nervous system, characterized by the synchronized firing of neurons and the transmission of signals across synaptic junctions (NIH, 2023). It is not a discrete molecular target, such as a single receptor or enzyme, but rather a high-level physiological state or biological process resulting from the coordinated interaction of billions of cells and diverse molecular components (StatPearls, 2023). In the context of drug discovery, 'brain activity' is typically viewed as a functional readout or a therapeutic endpoint rather than the primary target itself. Most neuroactive pharmaceuticals exert their effects by binding to specific proteins—such as the Gamma-aminobutyric acid (GABA) receptors or voltage-gated sodium channels—to modulate this overarching activity. Pathological alterations in brain activity are hallmark features of conditions like epilepsy, where excessive synchronization leads to seizures, or Alzheimer’s disease, where activity levels decline due to neurodegeneration (Purves et al., Neuroscience, 2018). Monitoring brain activity through techniques like EEG or fMRI is essential for diagnosing neurological disorders and assessing the pharmacodynamic effects of drugs in development. Therefore, while brain activity is a critical focus of biomedical research, it remains a macroscopic physiological phenomenon rather than a singular therapeutic target.

Other names
Neuronal activityNeural activityCerebral activityNeurotransmissionElectrophysiological activity
02

Mechanism of action

Modulation of global or regional neuronal excitability through interaction with specific molecular targets such as ion channels, G protein-coupled receptors, and neurotransmitter transporters.

03

Biological functions

Signal transductionCognitionSensory processingMotor controlHomeostasis
04

Disease associations

EpilepsyNeurodegenerative diseasePsychiatric disorderStrokeTraumatic brain injury
05

Safety considerations

Central nervous system depressionSeizure inductionCognitive impairmentNeurotoxicitySedation
06

Interacting drugs

Diazepam

4 more in the full profile.

07

Biomarkers

Electroencephalogram (EEG) power spectraFunctional Magnetic Resonance Imaging (fMRI) BOLD signalPositron Emission Tomography (PET) glucose metabolismMagnetoencephalography (MEG) signals

Beyond the preview

Go deeper on Brain activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call